By definition, CIN is the elevation of serum creatinine (Scr) by ≥25% or N0.5 mg/dl from baseline within 48 h after excluding other possible risk factors for AKI such as nephrotoxins, hypotension, urinary obstruction, or atheromatous emboli. In most instances, it follows a self-limiting course with Scr levels maximum at day 3-5, and gradually AKI resolves within 7-10 days. There are several risk factors for CIN which are classified into two categories: patient and procedure-related. Patient-related risk factors are chronic kidney disease (CKD) [estimated glomerular filtration rate (eGFR) ≤ 60 ml/min], diabetes mellitus, age N 75 years, hypertension, hypotensive episode requiring inotropes, congestive heart failure (CHF), use of intra-aortic balloon pump, liver cirrhosis, and hypoalbuminemia. On the other hand, procedure-related risk factors comprise of high CM volume, high osmolality CM, ionic contrast, contrast viscosity, repeated use within 72 h and concomitant use of nephrotoxic drugs along with CM [4] .
Contrast agents have interactions with various medications so the physicians should look for those interactions to mitigate the hazardous implication of CM. We may need to withhold few drugs before contrast based procedures like metformin, renin inhibitors, angiotensinconverting enzyme inhibitors (ACEI), angiotensin receptor blocker (ARBs), non-steroidal anti-inflammatory drugs, loop diuretics and thiazide-like diuretics [5] . Primary angioplasty intervention in myocardial infarction cases have a higher risk of developing CIN compared to elective procedures. To prevent these implications, preemptive use of normal saline infusion and N-acetylcysteine may be helpful. Notably, it should be given many hours before starting the procedure [6] .
Renal dysfunction is indisputably related to cardiovascular disease causing significant death and disability, typically when there is underlying acute coronary syndrome (ACS) [7] . Retrospective cohort study performed by Roubín et al. to contemplate possible reciprocal relation between a-fib and CIN, involving 1520 participants supported that CIN is an independent predictor of the occurrence of new-onset A-Fib (p-value b 0.001). Several hypotheses were suggested to explain this unidirectional association between CIN and A-Fib like influence on renin-angiotensin-aldosterone system and the inflammatory pathway [8] . Thus, CIN carries a potential risk for new-onset A-Fib. Therefore, CIN after CM exposure should make the physician more vigilant for the possible hazard of A-Fib in these subjects.
A-Fib prognosis is intertwined with underlying cardiovascular morbidity, and mortality and that, in turn, is significantly related to 
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Another retrospective study was done by Balli et al. [10] .
The pathogenesis and risk factors for CIN are multifactorial and remain poorly understood. Nevertheless, the estimation of an individual's risk profile is extremely important in the prevention of CIN occurrence, even if the patient's baseline renal dysfunction is minimal. Considering the above studies, we can assume that there is an important bilateral relationship between A-Fib and CIN. However, the question remains whether CIN increases the risk of A-Fib in patients without cardiovascular disease or vice-versa. The big shortcomings of previous studies were small sample size and retrospective nature of study; therefore, we need a larger sample size and additional prospective studies for better understanding of this issue.
